{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T05:07:42Z","timestamp":1737695262330,"version":"3.33.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,22]]},"DOI":"10.7759\/cureus.77853","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T05:15:27Z","timestamp":1737609327000},"source":"Crossref","is-referenced-by-count":0,"title":["High-Dose Insulin Therapy for Refractory Shock in a Polypharmacy Overdose of Calcium Channel Blocker and Oral Hypoglycemic Agent: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Vinayak","family":"S R","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bipenthung N","family":"Jami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin J","family":"Mangaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnakumar","family":"R S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladson","family":"Vineeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandni","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2165\/00139709-200423040-00003","article-title":"Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity","volume":"23","author":"DeWitt CR","year":"2004","unstructured":"DeWitt CR, Waksman JC. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev. 2004, 23:223-38. 10.2165\/00139709-200423040-00003","journal-title":"Toxicol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E436","article-title":"High-dose insulin therapy for calcium-channel blocker overdose","volume":"39","author":"Shepherd G","year":"2005","unstructured":"Shepherd G, Klein-Schwartz W. High-dose insulin therapy for calcium-channel blocker overdose. Ann Pharmacother. 2005, 39:923-30. 10.1345\/aph.1E436","journal-title":"Ann Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/cc4938","article-title":"Bench-to-bedside review: hyperinsulinaemia\/euglycaemia therapy in the management of overdose of calcium-channel blockers","volume":"10","author":"Lheureux PE","year":"2006","unstructured":"Lheureux PE, Zahir S, Gris M, Derrey AS, Penaloza A. Bench-to-bedside review: hyperinsulinaemia\/euglycaemia therapy in the management of overdose of calcium-channel blockers. Crit Care. 2006, 10:212. 10.1186\/cc4938","journal-title":"Crit Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199507000-00016","article-title":"Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine","volume":"23","author":"Kline JA","year":"1995","unstructured":"Kline JA, Leonova E, Raymond RM. Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine. Crit Care Med. 1995, 23:1251-63. 10.1097\/00003246-199507000-00016","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199605000-00015","article-title":"Myocardial metabolism during graded intraportal verapamil infusion in awake dogs","volume":"27","author":"Kline JA","year":"1996","unstructured":"Kline JA, Leonova E, Williams TC, Schroeder JD, Watts JA. Myocardial metabolism during graded intraportal verapamil infusion in awake dogs. J Cardiovasc Pharmacol. 1996, 27:719-26. 10.1097\/00005344-199605000-00015","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1997.8195","article-title":"The diabetogenic effects of acute verapamil poisoning","volume":"145","author":"Kline JA","year":"1997","unstructured":"Kline JA, Raymond RM, Schroeder JD, Watts JA. The diabetogenic effects of acute verapamil poisoning. Toxicol Appl Pharmacol. 1997, 145:357-62. 10.1006\/taap.1997.8195","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2008.00088.x","article-title":"Verapamil toxicity dysregulates the phosphatidylinositol 3-kinase pathway","volume":"15","author":"Bechtel LK","year":"2008","unstructured":"Bechtel LK, Haverstick DM, Holstege CP. Verapamil toxicity dysregulates the phosphatidylinositol 3-kinase pathway. Acad Emerg Med. 2008, 15:368-74. 10.1111\/j.1553-2712.2008.00088.x","journal-title":"Acad Emerg Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.497461","article-title":"Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium","volume":"111","author":"von Lewinski D","year":"2005","unstructured":"von Lewinski D, Bruns S, Walther S, K\u00f6gler H, Pieske B. Insulin causes [Ca2+]i-dependent and [Ca2+]i-independent positive inotropic effects in failing human myocardium. Circulation. 2005, 111:2588-95. 10.1161\/CIRCULATIONAHA.104.497461","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2010.00695.x","article-title":"Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model","volume":"17","author":"Holger JS","year":"2010","unstructured":"Holger JS, Dries DJ, Barringer KW, Peake BJ, Flottemesch TJ, Marini JJ. Cardiovascular and metabolic effects of high-dose insulin in a porcine septic shock model. Acad Emerg Med. 2010, 17:429-35. 10.1111\/j.1553-2712.2010.00695.x","journal-title":"Acad Emerg Med"},{"key":"ref10","article-title":"Hyperinsulinemic-euglycemic therapy for intoxication with calcium channel blockers","volume":"97","author":"Ortiz-Mu\u00f1oz L","year":"2005","unstructured":"Ortiz-Mu\u00f1oz L, Rodriguez-Ospina LF, Figueroa-Gonzalez M. Hyperinsulinemic-euglycemic therapy for intoxication with calcium channel blockers. Bol Asoc Med P R. 2005, 97:182-9.","journal-title":"Bol Asoc Med P R"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1081\/clt-100102437","article-title":"Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning","volume":"37","author":"Yuan TH","year":"1999","unstructured":"Yuan TH, Kerns WP 2nd, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol. 1999, 37:463-74. 10.1081\/clt-100102437","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0300-9572(03)00026-1","article-title":"Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review","volume":"57","author":"Marques M","year":"2003","unstructured":"Marques M, Gomes E, de Oliveira J. Treatment of calcium channel blocker intoxication with insulin infusion: case report and literature review. Resuscitation. 2003, 57:211-3. 10.1016\/s0300-9572(03)00026-1","journal-title":"Resuscitation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.582471","article-title":"High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning","volume":"49","author":"Engebretsen KM","year":"2011","unstructured":"Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol (Phila). 2011, 49:277-83. 10.3109\/15563650.2011.582471","journal-title":"Clin Toxicol (Phila)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-007-0768-y","article-title":"Relative safety of hyperinsulinaemia\/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study","volume":"33","author":"Greene SL","year":"2007","unstructured":"Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of hyperinsulinaemia\/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study. Intensive Care Med. 2007, 33:2019-24. 10.1007\/s00134-007-0768-y","journal-title":"Intensive Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-020-00796-2","article-title":"Persistent hyperinsulinemia following high-dose insulin therapy: a case report","volume":"16","author":"Corcoran JN","year":"2020","unstructured":"Corcoran JN, Jacoby KJ, Olives TD, Bangh SA, Cole JB. Persistent hyperinsulinemia following high-dose insulin therapy: a case report. J Med Toxicol. 2020, 16:465-9. 10.1007\/s13181-020-00796-2","journal-title":"J Med Toxicol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/303373-high-dose-insulin-therapy-for-refractory-shock-in-a-polypharmacy-overdose-of-calcium-channel-blocker-and-oral-hypoglycemic-agent-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T05:15:30Z","timestamp":1737609330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/303373-high-dose-insulin-therapy-for-refractory-shock-in-a-polypharmacy-overdose-of-calcium-channel-blocker-and-oral-hypoglycemic-agent-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.77853","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}